{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T04:06:07Z","timestamp":1787889967102,"version":"build-2784847793"},"reference-count":78,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2024,8,13]],"date-time":"2024-08-13T00:00:00Z","timestamp":1723507200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,8,13]],"date-time":"2024-08-13T00:00:00Z","timestamp":1723507200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Manipal Academy of Higher Education - Kasturba Medical College, Mangalore"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Pharmacol"],"published-print":{"date-parts":[[2024,11]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Purpose<\/jats:title>\n                <jats:p>Isoniazid, a first-line antitubercular drug, is associated with nervous system adverse drug reactions such as seizures, peripheral neuropathy, and psychosis. This systematic review of case reports and case series aimed to characterize the demographic, social, and clinical factors associated with isoniazid-induced psychosis in patients with active tuberculosis (TB) and those who received isoniazid for latent TB infection (LTBI).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We comprehensively searched the Embase, PubMed, and Scopus databases to identify relevant studies published between the date of inception of the database and June 2024.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>A total of 28 studies, including 21 case reports and 7 case series involved 37 patients who developed isoniazid-induced psychosis. A higher frequency of isoniazid-induced psychosis was observed during the first 2\u00a0months of treatment, with a relatively early onset observed among patients aged 18\u00a0years or less. Delusions and\/or hallucinations are the common symptoms of isoniazid-induced psychosis. Psychomotor disturbances, disorganized speech or formal thought disorder, disorganized or abnormal behaviour, and neuropsychiatric symptoms (sleep disturbances, hostility or aggression, confusion, affective symptoms, anxiety symptoms, and cognitive difficulties) were the other symptoms observed in the included studies. More than 80% of cases rechallenged with isoniazid resulted in the recurrence of psychotic symptoms.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Patients with TB and LTBI should be assessed for psychotic and neuropsychiatric symptoms during isoniazid therapy, mainly in the first 2\u00a0months. Further research is required to understand the impact of underlying risk factors, such as genetic predisposition and isoniazid pharmacokinetics, as well as the clinical utility and dosage recommendations of pyridoxine for managing isoniazid-induced psychosis.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s00228-024-03738-x","type":"journal-article","created":{"date-parts":[[2024,8,13]],"date-time":"2024-08-13T03:43:43Z","timestamp":1723520623000},"page":"1725-1740","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Characteristics of isoniazid-induced psychosis: a systematic review of case reports and case series"],"prefix":"10.1007","volume":"80","author":[{"given":"Keerthanaa","family":"B","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rashmi","family":"Appaji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Levin","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tejaswini","family":"Baral","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Skanda","family":"N","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Chaithra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonal Sekhar","family":"M","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kavitha","family":"Saravu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krishna","family":"Undela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahadev","family":"Rao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,8,13]]},"reference":[{"issue":"12","key":"3738_CR1","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.1513\/AnnalsATS.201509-632PS","volume":"12","author":"JF Murray","year":"2015","unstructured":"Murray JF, Schraufnagel DE, Hopewell PC (2015) Treatment of tuberculosis. A historical perspective. Ann Am Thorac Soc 12(12):1749\u20131759. https:\/\/doi.org\/10.1513\/AnnalsATS.201509-632PS","journal-title":"Ann Am Thorac Soc"},{"issue":"8","key":"3738_CR2","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1007\/s40263-019-00649-9","volume":"33","author":"MK Bangert","year":"2019","unstructured":"Bangert MK, Hasbun R (2019) Neurological and psychiatric adverse effects of antimicrobials. CNS Drugs 33(8):727\u2013753. https:\/\/doi.org\/10.1007\/s40263-019-00649-9","journal-title":"CNS Drugs"},{"issue":"1","key":"3738_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ijantimicag.2017.01.027","volume":"50","author":"S Esposito","year":"2017","unstructured":"Esposito S, Canevini MP, Principi N (2017) Complications associated with antibiotic administration: neurological adverse events and interference with antiepileptic drugs. Int J Antimicrob Agents 50(1):1\u20138. https:\/\/doi.org\/10.1016\/j.ijantimicag.2017.01.027","journal-title":"Int J Antimicrob Agents"},{"issue":"8","key":"3738_CR4","doi-asserted-by":"publisher","first-page":"655","DOI":"10.2165\/11534340-000000000-00000","volume":"24","author":"JS Kass","year":"2010","unstructured":"Kass JS, Shandera WX (2010) Nervous system effects of antituberculosis therapy. CNS Drugs 24(8):655\u2013667. https:\/\/doi.org\/10.2165\/11534340-000000000-00000","journal-title":"CNS Drugs"},{"issue":"1","key":"3738_CR5","doi-asserted-by":"publisher","first-page":"e60","DOI":"10.1097\/PEC.0000000000001555","volume":"37","author":"IK Sharawat","year":"2021","unstructured":"Sharawat IK, Dawman L (2021) Toddler with intermittent abnormal behavior: is it isoniazid-induced psychosis? Pediatr Emerg Care 37(1):e60\u2013e61. https:\/\/doi.org\/10.1097\/PEC.0000000000001555","journal-title":"Pediatr Emerg Care"},{"issue":"11","key":"3738_CR6","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1093\/MILMED\/161.11.707","volume":"161","author":"JA Bourgeois","year":"1996","unstructured":"Bourgeois JA, Zelenko M, Waraich BS (1996) Psychotic disorder associated with isoniazid. Mil Med 161(11):707. https:\/\/doi.org\/10.1093\/MILMED\/161.11.707","journal-title":"Mil Med"},{"issue":"4","key":"3738_CR7","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1016\/j.genhosppsych.2013.03.018","volume":"35","author":"AM Doherty","year":"2013","unstructured":"Doherty AM, Kelly J, McDonald C et al (2013) A review of the interplay between tuberculosis and mental health. Gen Hosp Psychiatry 35(4):398\u2013406. https:\/\/doi.org\/10.1016\/j.genhosppsych.2013.03.018","journal-title":"Gen Hosp Psychiatry"},{"issue":"1","key":"3738_CR8","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/BF03259859","volume":"2","author":"MR Holdiness","year":"1987","unstructured":"Holdiness MR (1987) Neurological manifestations and toxicities of the antituberculosis drugs. A review. Med Toxicol 2(1):33\u201351. https:\/\/doi.org\/10.1007\/BF03259859","journal-title":"Med Toxicol"},{"issue":"4","key":"3738_CR9","doi-asserted-by":"publisher","first-page":"214","DOI":"10.3109\/10673229709000304","volume":"5","author":"H Sternbach","year":"1997","unstructured":"Sternbach H, State R (1997) Antibiotics: neuropsychiatric effects and psychotropic interactions. Harv Rev Psychiatry 5(4):214\u2013226. https:\/\/doi.org\/10.3109\/10673229709000304","journal-title":"Harv Rev Psychiatry"},{"issue":"5","key":"3738_CR10","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1007\/s40261-017-0498-z","volume":"37","author":"N Zareifopoulos","year":"2017","unstructured":"Zareifopoulos N, Panayiotakopoulos G (2017) Neuropsychiatric effects of antimicrobial agents. Clin Drug Investig 37(5):423\u2013437. https:\/\/doi.org\/10.1007\/s40261-017-0498-z","journal-title":"Clin Drug Investig"},{"issue":"1","key":"3738_CR11","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1111\/bdi.13272","volume":"25","author":"AICB Samouco","year":"2023","unstructured":"Samouco AICB, Alves SP (2023) Isoniazid-induced mania and the history of antidepressant drugs: Case report and literature review. Bipolar Disord 25(1):84\u201387. https:\/\/doi.org\/10.1111\/bdi.13272","journal-title":"Bipolar Disord"},{"key":"3738_CR12","doi-asserted-by":"publisher","first-page":"4272941","DOI":"10.1155\/2019\/4272941","volume":"2019","author":"J Gomes","year":"2019","unstructured":"Gomes J, Dur\u00e3es D, Sousa A et al (2019) Isoniazid-induced acute psychosis in a patient with pleural tuberculosis. Case Rep Psychiatry 2019:4272941. https:\/\/doi.org\/10.1155\/2019\/4272941","journal-title":"Case Rep Psychiatry"},{"issue":"6","key":"3738_CR13","doi-asserted-by":"publisher","first-page":"VD01","DOI":"10.7860\/JCDR\/2015\/12450.6130","volume":"9","author":"S Arya","year":"2015","unstructured":"Arya S, Sukhija G, Singh H (2015) Acute psychosis after recent isoniazid initiation. J Clin Diagn Res 9(6):VD01\u2013VD02. https:\/\/doi.org\/10.7860\/JCDR\/2015\/12450.6130","journal-title":"J Clin Diagn Res"},{"issue":"4","key":"3738_CR14","doi-asserted-by":"publisher","first-page":"149","DOI":"10.4103\/1817-1737.43083","volume":"3","author":"R Prasad","year":"2008","unstructured":"Prasad R, Garg R, Verma SK (2008) Isoniazid- and ethambutol-induced psychosis. Ann Thorac Med 3(4):149\u2013151. https:\/\/doi.org\/10.4103\/1817-1737.43083","journal-title":"Ann Thorac Med"},{"key":"3738_CR15","doi-asserted-by":"publisher","first-page":"678","DOI":"10.12688\/f1000research.24469.1","volume":"9","author":"MS Cumpston","year":"2020","unstructured":"Cumpston MS, McKenzie JE, Thomas J et al (2020) The use of \u201cPICO for synthesis\u201d and methods for synthesis without meta-analysis: protocol for a survey of current practice in systematic reviews of health interventions. F1000Res 9:678","journal-title":"F1000Res"},{"key":"3738_CR16","doi-asserted-by":"publisher","unstructured":"American Psychiatric Association, DSM-5 Task Force (2013) Diagnostic and statistical manual of mental disorders: DSM-5. 5th ed. American Psychiatric Publishing, Inc., Arlington. https:\/\/doi.org\/10.1176\/appi.books.9780890425596","DOI":"10.1176\/appi.books.9780890425596"},{"issue":"1","key":"3738_CR17","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1186\/s13643-021-01626-4","volume":"10","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM et al (2021) The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. The BMJ 10(1):89. https:\/\/doi.org\/10.1186\/s13643-021-01626-4","journal-title":"The BMJ"},{"key":"3738_CR18","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1136\/bmjebm-2017-110853","volume":"23","author":"MH Murad","year":"2018","unstructured":"Murad MH, Sultan S, Haffar S et al (2018) Methodological quality and synthesis of case series and case reports. BMJ Evid Based Med 23:60\u201363. https:\/\/doi.org\/10.1136\/bmjebm-2017-110853","journal-title":"BMJ Evid Based Med"},{"key":"3738_CR19","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1345\/aph.17377","volume":"32","author":"AO Alao","year":"1998","unstructured":"Alao AO, Yolles JC (1998) Isoniazid-induced psychosis. Ann Pharmacother 32:889\u2013891. https:\/\/doi.org\/10.1345\/aph.17377","journal-title":"Ann Pharmacother"},{"issue":"4","key":"3738_CR20","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/j.ijpam.2020.03.012","volume":"7","author":"S Alfawaz","year":"2020","unstructured":"Alfawaz S, Alattas N, Alhammadi M et al (2020) Acute psychosis secondary to isoniazid in pediatric pulmonary tuberculosis: a case report and literature review. Int J Pediatr Adolesc Med 7(4):196\u2013198. https:\/\/doi.org\/10.1016\/j.ijpam.2020.03.012","journal-title":"Int J Pediatr Adolesc Med"},{"issue":"8654","key":"3738_CR21","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/s0140-6736(89)90344-9","volume":"2","author":"R Ball","year":"1989","unstructured":"Ball R, Rosser R (1989) Psychosis, and anti-tuberculosis therapy. Lancet 2(8654):105. https:\/\/doi.org\/10.1016\/s0140-6736(89)90344-9","journal-title":"Lancet"},{"issue":"10","key":"3738_CR22","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1089\/cap.2014.0065","volume":"25","author":"MB Baytunca","year":"2015","unstructured":"Baytunca MB, Erermis S, Bildik T et al (2015) Isoniazid-induced psychosis with obsessive-compulsive symptoms (schizo-obsessive disorder) in a female child. J Child Adolesc Psychopharmacol 25(10):819\u2013820. https:\/\/doi.org\/10.1089\/cap.2014.0065","journal-title":"J Child Adolesc Psychopharmacol"},{"issue":"2","key":"3738_CR23","doi-asserted-by":"publisher","first-page":"e68","DOI":"10.1176\/appi.neuropsych.12020022","volume":"25","author":"B Demartini","year":"2013","unstructured":"Demartini B, Camisasca M, Zuin M et al (2013) A case of isoniazid-induced delirium. J Neuropsychiatry Clin Neurosci 25(2):e68\u2013e69. https:\/\/doi.org\/10.1176\/appi.neuropsych.12020022","journal-title":"J Neuropsychiatry Clin Neurosci"},{"issue":"3","key":"3738_CR24","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1046\/j.1440-1754.1999.00344.x","volume":"35","author":"T Duke","year":"1999","unstructured":"Duke T, Mai M (1999) Meningitis, or madness: a delicate balance. J Paediatr Child Health 35(3):319\u2013320. https:\/\/doi.org\/10.1046\/j.1440-1754.1999.00344.x","journal-title":"J Paediatr Child Health"},{"issue":"3","key":"3738_CR25","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/s0007-0971(62)80045-x","volume":"56","author":"H Duncan","year":"1962","unstructured":"Duncan H, Kerr D (1962) Toxic psychosis due to isoniazid. Br J Dis Chest 56(3):131\u2013138. https:\/\/doi.org\/10.1016\/s0007-0971(62)80045-x","journal-title":"Br J Dis Chest"},{"issue":"6","key":"3738_CR26","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1016\/S0033-3182(93)71836-8","volume":"34","author":"W Gnam","year":"1993","unstructured":"Gnam W, Flint A, Goldbloom D (1993) Isoniazid-induced hallucinosis: response to pyridoxine. Psychosomatics 34(6):537\u2013539. https:\/\/doi.org\/10.1016\/S0033-3182(93)71836-8","journal-title":"Psychosomatics"},{"issue":"1","key":"3738_CR27","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1097\/00006565-200202000-00008","volume":"18","author":"R Iannaccone","year":"2002","unstructured":"Iannaccone R, Sue YJ, Avner JR (2002) Suicidal psychosis secondary to isoniazid. Pediatr Emerg Care 18(1):25\u201327. https:\/\/doi.org\/10.1097\/00006565-200202000-00008","journal-title":"Pediatr Emerg Care"},{"issue":"11","key":"3738_CR28","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1177\/106002809402801131","volume":"28","author":"ZY Ibrahim","year":"1994","unstructured":"Ibrahim ZY, Menke JJ (1994) Comment: isoniazid-induced psychosis. Ann Pharmacother 28(11):1311. https:\/\/doi.org\/10.1177\/106002809402801131","journal-title":"Ann Pharmacother"},{"key":"3738_CR29","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1007\/s10072-015-2105-5","volume":"36","author":"O Kargiotis","year":"2015","unstructured":"Kargiotis O, Marangos M, Polychronopoulos P (2015) An unusual case of isoniazid toxicity. Neurol Sci 36:1037\u20131039. https:\/\/doi.org\/10.1007\/s10072-015-2105-5","journal-title":"Neurol Sci"},{"issue":"1","key":"3738_CR30","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1159\/000530779","volume":"15","author":"S Khanna","year":"2023","unstructured":"Khanna S, Pant S, Khanna H (2023) Isoniazid-induced psychosis in a patient with pulmonary tuberculosis: a case report. Case Rep Neurol 15(1):76\u201380. https:\/\/doi.org\/10.1159\/000530779","journal-title":"Case Rep Neurol"},{"issue":"2","key":"3738_CR31","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/0041-3879(89)90041-x","volume":"70","author":"A Madan","year":"1989","unstructured":"Madan A, Jain NK, Sharma TN et al (1989) Attempted suicide following treatment with isoniazid. Tubercle 70(2):147\u2013149. https:\/\/doi.org\/10.1016\/0041-3879(89)90041-x","journal-title":"Tubercle"},{"issue":"2","key":"3738_CR32","doi-asserted-by":"publisher","first-page":"142","DOI":"10.5530\/IJOPP.10.2.29","volume":"10","author":"VB Menon","year":"2017","unstructured":"Menon VB, Shaji R, Pereira P (2017) Isoniazid associated psychosis: a case series of 3 patients. Indian J Phar Pract 10(2):142\u2013146. https:\/\/doi.org\/10.5530\/IJOPP.10.2.29","journal-title":"Indian J Phar Pract"},{"issue":"2","key":"3738_CR33","doi-asserted-by":"publisher","first-page":"73","DOI":"10.5005\/jp-journals-10070-8010","volume":"10","author":"S Mukherjee","year":"2023","unstructured":"Mukherjee S, Roy S (2023) Acute psychosis secondary to isoniazid in a patient with pulmonary tuberculosis. Bengal Physician J 10(2):73\u201374","journal-title":"Bengal Physician J"},{"issue":"11","key":"3738_CR34","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2019-231919","volume":"12","author":"H Nagano","year":"2019","unstructured":"Nagano H, Miura T, Ueda T (2019) Mania induced by isoniazid preventive therapy during steroid treatment for rheumatoid arthritis and organising pneumonia. BMJ Case Rep 12(11):e231919. https:\/\/doi.org\/10.1136\/bcr-2019-231919","journal-title":"BMJ Case Rep"},{"issue":"4","key":"3738_CR35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.9734\/IJMPCR\/2016\/23675","volume":"6","author":"SO Oninla","year":"2016","unstructured":"Oninla SO, Oyedeji GA, Oninla OA et al (2016) Isoniazid-induced psychosis in 2 children treated for tuberculosis: case reports and literature review. Int J Med Pharm Case Rep 6(4):1\u20136. https:\/\/doi.org\/10.9734\/IJMPCR\/2016\/23675","journal-title":"Int J Med Pharm Case Rep"},{"issue":"1","key":"3738_CR36","first-page":"25","volume":"14","author":"S Rajpal","year":"2000","unstructured":"Rajpal S, Kumar R, Dhingra V et al (2000) Isoniazid-induced psychosis \u2013 a case report. Indian J Allergy Appl Immunol 14(1):25\u201327","journal-title":"Indian J Allergy Appl Immunol"},{"issue":"2","key":"3738_CR37","doi-asserted-by":"publisher","first-page":"161","DOI":"10.5958\/2394-2061.2018.00019.8","volume":"9","author":"H Singh","year":"2018","unstructured":"Singh H, Devi HJG, Chabaria M et al (2018) Isoniazid associated psychosis: case series from a tertiary care centre. Open J Psychiatry Allied Sci 9(2):161\u2013163. https:\/\/doi.org\/10.5958\/2394-2061.2018.00019.8","journal-title":"Open J Psychiatry Allied Sci"},{"issue":"5047","key":"3738_CR38","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1136\/bmj.2.5047.743","volume":"2","author":"SL Jackson","year":"1957","unstructured":"Jackson SL (1957) Psychosis due to isoniazid. Br Med J 2(5047):743\u2013746. https:\/\/doi.org\/10.1136\/bmj.2.5047.743","journal-title":"Br Med J"},{"issue":"4","key":"3738_CR39","doi-asserted-by":"publisher","first-page":"379","DOI":"10.5350\/DAJPN2016290411","volume":"29","author":"G Umut","year":"2016","unstructured":"Umut G, Dernek B, Kucukparlak I et al (2016) Acute psychotic attack under isoniazid treatment: a case report. Dusunen Adam J Psychiatry Neurol Sci 29(4):379\u2013381. https:\/\/doi.org\/10.5350\/DAJPN2016290411","journal-title":"Dusunen Adam J Psychiatry Neurol Sci"},{"issue":"3","key":"3738_CR40","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1001\/archneurpsyc.1954.02330030055005","volume":"72","author":"WS Wiedorn","year":"1954","unstructured":"Wiedorn WS, Ervin F (1954) Schizophrenic like psychotic reactions with administration of isoniazid. AMA Arch Neurol 72(3):321\u2013324. https:\/\/doi.org\/10.1001\/archneurpsyc.1954.02330030055005","journal-title":"AMA Arch Neurol"},{"issue":"1","key":"3738_CR41","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.genhosppsych.2006.10.010","volume":"29","author":"AE Witkowski","year":"2007","unstructured":"Witkowski AE, Manabat CG, Bourgeois JA (2007) Isoniazid-associated psychosis. Gen Hosp Psychiatry 29(1):85\u201386. https:\/\/doi.org\/10.1016\/j.genhosppsych.2006.10.010","journal-title":"Gen Hosp Psychiatry"},{"issue":"7","key":"3738_CR42","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1177\/070674378803300729","volume":"33","author":"SK Chaturvedi","year":"1988","unstructured":"Chaturvedi SK, Upadhyaya M (1988) Secondary mania in a patient receiving isonicotinic acid hydrazide and pyridoxine: case report. Can J Psychiatry 33(7):675\u2013676. https:\/\/doi.org\/10.1177\/070674378803300729","journal-title":"Can J Psychiatry"},{"key":"3738_CR43","unstructured":"Global Tuberculosis report 2022 (2022) https:\/\/www.who.int\/publications\/i\/item\/9789240061729. Accessed 3 June 2023"},{"issue":"4","key":"3738_CR44","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1176\/appi.psy.47.4.360","volume":"47","author":"M Adams","year":"2006","unstructured":"Adams M, Tavakoli H (2006) Gatifloxacin-induced hallucinations in a 19-year-old man. Psychosomatics 47(4):360. https:\/\/doi.org\/10.1176\/appi.psy.47.4.360","journal-title":"Psychosomatics"},{"issue":"5","key":"3738_CR45","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1192\/bjp.168.5.651b","volume":"168","author":"K Davison","year":"1996","unstructured":"Davison K, Roth M (1996) Substance-induced psychosis. Br J Psychiatry 168(5):651. https:\/\/doi.org\/10.1192\/bjp.168.5.651b","journal-title":"Br J Psychiatry"},{"issue":"4","key":"3738_CR46","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1258\/095646207780658863","volume":"18","author":"SJ Martin","year":"2007","unstructured":"Martin SJ, Bowden FJ (2007) Ethambutol toxicity manifesting as acute onset psychosis. Int J STD AIDS 18(4):287\u2013288. https:\/\/doi.org\/10.1258\/095646207780658863","journal-title":"Int J STD AIDS"},{"key":"3738_CR47","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/489865","volume":"2013","author":"A Pachi","year":"2013","unstructured":"Pachi A, Bratis D, Moussas G et al (2013) Psychiatric morbidity, and other factors affecting treatment adherence in pulmonary tuberculosis patients. Tuberc Res Treat 2013:489865. https:\/\/doi.org\/10.1155\/2013\/489865","journal-title":"Tuberc Res Treat"},{"key":"3738_CR48","doi-asserted-by":"publisher","first-page":"1173619","DOI":"10.3389\/fmed.2023.1173619","volume":"10","author":"A Li","year":"2023","unstructured":"Li A, Yuan SY, Li QG et al (2023) Prevalence and risk factors of malnutrition in patients with pulmonary tuberculosis: a systematic review and meta-analysis. Front Med (Lausanne) 10:1173619. https:\/\/doi.org\/10.3389\/fmed.2023.1173619","journal-title":"Front Med (Lausanne)"},{"issue":"2","key":"3738_CR49","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.psym.2019.06.003","volume":"61","author":"BB Brodrick","year":"2020","unstructured":"Brodrick BB, Jacobs MA, McAdams CJ (2020) Psychosis in anorexia nervosa: a case report and review of the literature. Psychosomatics 61(2):181\u2013187. https:\/\/doi.org\/10.1016\/j.psym.2019.06.003","journal-title":"Psychosomatics"},{"issue":"5","key":"3738_CR50","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0064915","volume":"8","author":"J Gao","year":"2013","unstructured":"Gao J, Zheng P, Fu H (2013) Prevalence of TB\/HIV co-infection in countries except China: a systematic review and meta-analysis. PLoS ONE 8(5):e64915. https:\/\/doi.org\/10.1371\/journal.pone.0064915","journal-title":"PLoS ONE"},{"issue":"8","key":"3738_CR51","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1097\/NMD.0000000000001366","volume":"209","author":"U Chhagan","year":"2021","unstructured":"Chhagan U, Ntlantsana V, Tomita A et al (2021) The dual burden of HIV infection and first-episode psychosis in Africa: a systematic review and meta-analysis. J Nerv Ment Dis 209(8):600\u2013608. https:\/\/doi.org\/10.1097\/NMD.0000000000001366","journal-title":"J Nerv Ment Dis"},{"issue":"7342","key":"3738_CR52","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1136\/bmj.324.7342.879","volume":"324","author":"ME Wise","year":"2002","unstructured":"Wise ME, Mistry K, Reid S (2002) Drug points: neuropsychiatric complications of nevirapine treatment. BMJ 324(7342):879. https:\/\/doi.org\/10.1136\/bmj.324.7342.879","journal-title":"BMJ"},{"issue":"2","key":"3738_CR53","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1046\/j.1468-1293.2003.00142.x","volume":"4","author":"R Foster","year":"2003","unstructured":"Foster R, Olajide D, Everall IP (2003) Antiretroviral therapy-induced psychosis: case report and brief review of the literature. HIV Med 4(2):139\u2013144. https:\/\/doi.org\/10.1046\/j.1468-1293.2003.00142.x","journal-title":"HIV Med"},{"issue":"1","key":"3738_CR54","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/s40261-017-0579-z","volume":"38","author":"JT Masuka","year":"2018","unstructured":"Masuka JT, Chipangura P, Nyambayo PP et al (2018) A comparison of adverse drug reaction profiles in patients on antiretroviral and antitubercular treatment in Zimbabwe. Clin Drug Investig 38(1):9\u201317. https:\/\/doi.org\/10.1007\/s40261-017-0579-z","journal-title":"Clin Drug Investig"},{"key":"3738_CR55","volume-title":"Isoniazid","author":"C O\u2019Connor","year":"2024","unstructured":"O\u2019Connor C, Patel P, Brady MF (2024) Isoniazid. StatPearls Publishing, Treasure Island (FL)"},{"issue":"10","key":"3738_CR56","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.1007\/s00228-022-03362-7","volume":"78","author":"L Thomas","year":"2022","unstructured":"Thomas L, Raju AP, Chaithra et al (2022) Influence of N-acetyltransferase 2 (NAT2) genotype\/single nucleotide polymorphisms on clearance of isoniazid in tuberculosis patients: a systematic review of population pharmacokinetic models. Eur J Clin Pharmacol 78(10):1535\u20131553. https:\/\/doi.org\/10.1007\/s00228-022-03362-7","journal-title":"Eur J Clin Pharmacol"},{"issue":"12","key":"3738_CR57","doi-asserted-by":"publisher","first-page":"2747","DOI":"10.1111\/bcp.13722","volume":"84","author":"M Zhang","year":"2018","unstructured":"Zhang M, Wang S, Wilffert B et al (2018) The association between the NAT2 genetic polymorphisms and risk of DILI during anti-TB treatment: a systematic review and meta-analysis. Br J Clin Pharmacol 84(12):2747\u20132760. https:\/\/doi.org\/10.1111\/bcp.13722","journal-title":"Br J Clin Pharmacol"},{"issue":"3","key":"3738_CR58","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1080\/17512433.2024.2311314","volume":"17","author":"L Thomas","year":"2024","unstructured":"Thomas L, Raju AP, Chaithra S et al (2024) Influence of N-acetyltransferase 2 polymorphisms and clinical variables on liver function profile of tuberculosis patients. Expert Rev Clin Pharmacol 17(3):263\u2013274. https:\/\/doi.org\/10.1080\/17512433.2024.2311314","journal-title":"Expert Rev Clin Pharmacol"},{"issue":"8","key":"3738_CR59","doi-asserted-by":"publisher","first-page":"4079","DOI":"10.1128\/AAC.00672-13","volume":"57","author":"E Ben-Chetrit","year":"2013","unstructured":"Ben-Chetrit E, Rothstein N, Munter G (2013) Ciprofloxacin-induced psychosis. Antimicrob Agents Chemother 57(8):4079. https:\/\/doi.org\/10.1128\/AAC.00672-13","journal-title":"Antimicrob Agents Chemother"},{"issue":"10","key":"3738_CR60","doi-asserted-by":"publisher","first-page":"1402","DOI":"10.1176\/ajp.148.10.1402","volume":"148","author":"M Bernardo","year":"1991","unstructured":"Bernardo M, Gatell JM, Parellada E (1991) Acute exacerbation of chronic schizophrenia in a patient treated with antituberculosis drugs. Am J Psychiatry 148(10):1402. https:\/\/doi.org\/10.1176\/ajp.148.10.1402","journal-title":"Am J Psychiatry"},{"issue":"6","key":"3738_CR61","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1176\/appi.psy.47.6.539","volume":"47","author":"S Bhalerao","year":"2006","unstructured":"Bhalerao S, Talsky A, Hansen K et al (2006) Ciprofloxacin-induced manic episode. Psychosomatics 47(6):539\u2013540. https:\/\/doi.org\/10.1176\/appi.psy.47.6.539","journal-title":"Psychosomatics"},{"issue":"2","key":"3738_CR62","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.clineuro.2004.05.006","volume":"107","author":"E Hakko","year":"2005","unstructured":"Hakko E, Mete B, Ozaras R et al (2005) Levofloxacin-induced delirium. Clin Neurol Neurosurg 107(2):158\u2013159. https:\/\/doi.org\/10.1016\/j.clineuro.2004.05.006","journal-title":"Clin Neurol Neurosurg"},{"issue":"5","key":"3738_CR63","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1046\/j.1440-1614.2003.01243.x","volume":"37","author":"CA McDonald","year":"2003","unstructured":"McDonald CA, Addis S (2003) Cephalosporin-induced psychosis. Aust N Z J Psychiatry 37(5):627\u2013628. https:\/\/doi.org\/10.1046\/j.1440-1614.2003.01243.x","journal-title":"Aust N Z J Psychiatry"},{"issue":"7\u20138","key":"3738_CR64","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1177\/106002809202600716","volume":"26","author":"RR Reeves","year":"1992","unstructured":"Reeves RR (1992) Ciprofloxacin-induced psychosis. Ann Pharmacother 26(7\u20138):930\u2013931. https:\/\/doi.org\/10.1177\/106002809202600716","journal-title":"Ann Pharmacother"},{"key":"3738_CR65","unstructured":"World Health Organization (1992) The ICD-10 classification of mental and behavioural disorders: clinical descriptions and diagnostic guidelines. World Health Organization, Geneva. https:\/\/www.who.int\/publications\/i\/item\/9241544228. Accessed 02 Jun 2024"},{"issue":"2","key":"3738_CR66","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1192\/bjp.168.2.135","volume":"168","author":"R Poole","year":"1996","unstructured":"Poole R, Brabbins C (1996) Drug induced psychosis. Br J Psychiatry 168(2):135\u2013138. https:\/\/doi.org\/10.1192\/bjp.168.2.135","journal-title":"Br J Psychiatry"},{"issue":"1","key":"3738_CR67","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1038\/s41398-021-01381-z","volume":"11","author":"K Toriumi","year":"2021","unstructured":"Toriumi K, Miyashita M, Suzuki K et al (2021) Vitamin B6 deficiency hyperactivates the noradrenergic system, leading to social deficits and cognitive impairment. Transl Psychiatry 11(1):262. https:\/\/doi.org\/10.1038\/s41398-021-01381-z","journal-title":"Transl Psychiatry"},{"issue":"3\u20134","key":"3738_CR68","doi-asserted-by":"publisher","first-page":"225","DOI":"10.3109\/00207459009000524","volume":"52","author":"R Sandyk","year":"1990","unstructured":"Sandyk R, Pardeshi R (1990) Pyridoxine improves drug-induced parkinsonism and psychosis in a schizophrenic patient. Int J Neurosci 52(3\u20134):225\u2013232. https:\/\/doi.org\/10.3109\/00207459009000524","journal-title":"Int J Neurosci"},{"issue":"9","key":"3738_CR69","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.1176\/appi.ajp.158.9.1511","volume":"158","author":"V Lerner","year":"2001","unstructured":"Lerner V, Miodownik C, Kaptsan A et al (2001) Vitamin B(6) in the treatment of tardive dyskinesia: a double-blind, placebo-controlled, crossover study. Am J Psychiatry 158(9):1511\u20131514. https:\/\/doi.org\/10.1176\/appi.ajp.158.9.1511","journal-title":"Am J Psychiatry"},{"issue":"11","key":"3738_CR70","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.4088\/jcp.v65n1118","volume":"65","author":"V Lerner","year":"2004","unstructured":"Lerner V, Bergman J, Statsenko N et al (2004) Vitamin B6 treatment in acute neuroleptic-induced akathisia: a randomized, double-blind, placebo-controlled study. J Clin Psychiatry 65(11):1550\u20131554. https:\/\/doi.org\/10.4088\/jcp.v65n1118","journal-title":"J Clin Psychiatry"},{"key":"3738_CR71","doi-asserted-by":"publisher","first-page":"CD010501","DOI":"10.1002\/14651858.CD010501.pub2","volume":"4","author":"AO Adelufosi","year":"2015","unstructured":"Adelufosi AO, Abayomi O (2015) Ojo TM (2015) Pyridoxal 5 phosphate for neuroleptic-induced tardive dyskinesia. Cochrane Database Syst Rev 4:CD010501. https:\/\/doi.org\/10.1002\/14651858.CD010501.pub2","journal-title":"Cochrane Database Syst Rev"},{"issue":"Suppl","key":"3738_CR72","first-page":"130","volume":"17","author":"N Shams-Alizadeh","year":"2018","unstructured":"Shams-Alizadeh N, Bakhshayesh H, Rezaei F et al (2018) Effect of vitamin B6 versus propranolol on antipsychotic-induced akathisia: a pilot comparative double-blind study. Iran J Pharm Res 17(Suppl):130\u2013135","journal-title":"Iran J Pharm Res"},{"issue":"10","key":"3738_CR73","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1345\/aph.19022","volume":"33","author":"TYK Chan","year":"1999","unstructured":"Chan TYK (1999) Pyridoxine ineffective in isoniazid-induced psychosis. Ann Pharmacother 33(10):1123\u20131124. https:\/\/doi.org\/10.1345\/aph.19022","journal-title":"Ann Pharmacother"},{"issue":"2","key":"3738_CR74","doi-asserted-by":"publisher","first-page":"190","DOI":"10.24911\/SJP.106-1584524803","volume":"22","author":"R Yadav","year":"2022","unstructured":"Yadav R, Kumar M, Kumar N et al (2022) Pyridoxine in isoniazid-induced psychosis. Sudan J Paediatr 22(2):190\u2013192. https:\/\/doi.org\/10.24911\/SJP.106-1584524803","journal-title":"Sudan J Paediatr"},{"issue":"8","key":"3738_CR75","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1192\/PB.BP.106.012328","volume":"31","author":"A Choke","year":"2007","unstructured":"Choke A, Perumal M, Howlett M (2007) Lorazepam prescription and monitoring in acute adult psychiatric wards. Psychiatri Bull 31(8):300\u2013303. https:\/\/doi.org\/10.1192\/PB.BP.106.012328","journal-title":"Psychiatri Bull"},{"key":"3738_CR76","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.d1126","volume":"342","author":"P Mackin","year":"2011","unstructured":"Mackin P, Thomas SH (2011) Atypical antipsychotic drugs. BMJ 342:d1126. https:\/\/doi.org\/10.1136\/bmj.d1126","journal-title":"BMJ"},{"issue":"1","key":"3738_CR77","doi-asserted-by":"publisher","first-page":"13189","DOI":"10.1038\/s41598-022-17410-w","volume":"12","author":"DS Atmaja","year":"2022","unstructured":"Atmaja DS, Yulistiani S et al (2022) Detection tools for prediction and identification of adverse drug reactions in older patients: a systematic review and meta-analysis. Sci Rep 12(1):13189. https:\/\/doi.org\/10.1038\/s41598-022-17410-w","journal-title":"Sci Rep"},{"issue":"6","key":"3738_CR78","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1016\/j.therap.2020.02.022","volume":"75","author":"K Bihan","year":"2020","unstructured":"Bihan K, Lebrun-Vignes B, Funck-Brentano C et al (2020) Uses of pharmacovigilance databases: an overview. Therapie 75(6):591\u2013598. https:\/\/doi.org\/10.1016\/j.therap.2020.02.022","journal-title":"Therapie"}],"container-title":["European Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-024-03738-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00228-024-03738-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-024-03738-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,7]],"date-time":"2024-10-07T06:03:15Z","timestamp":1728280995000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00228-024-03738-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,13]]},"references-count":78,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2024,11]]}},"alternative-id":["3738"],"URL":"https:\/\/doi.org\/10.1007\/s00228-024-03738-x","relation":{},"ISSN":["0031-6970","1432-1041"],"issn-type":[{"value":"0031-6970","type":"print"},{"value":"1432-1041","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,13]]},"assertion":[{"value":"13 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 August 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 August 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}